GB0900974D0 - Mutant pathogenic bacteria and live attenuated vaccine compositions - Google Patents

Mutant pathogenic bacteria and live attenuated vaccine compositions

Info

Publication number
GB0900974D0
GB0900974D0 GBGB0900974.7A GB0900974A GB0900974D0 GB 0900974 D0 GB0900974 D0 GB 0900974D0 GB 0900974 A GB0900974 A GB 0900974A GB 0900974 D0 GB0900974 D0 GB 0900974D0
Authority
GB
United Kingdom
Prior art keywords
pathogenic bacteria
vaccine compositions
live attenuated
attenuated vaccine
mutant pathogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0900974.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Plant Bioscience Ltd
Original Assignee
Plant Bioscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plant Bioscience Ltd filed Critical Plant Bioscience Ltd
Priority to GBGB0900974.7A priority Critical patent/GB0900974D0/en
Publication of GB0900974D0 publication Critical patent/GB0900974D0/en
Priority to PCT/GB2010/050086 priority patent/WO2010084350A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C12N9/1092—3-Phosphoshikimate 1-carboxyvinyltransferase (2.5.1.19), i.e. 5-enolpyruvylshikimate-3-phosphate synthase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1223—Phosphotransferases with a nitrogenous group as acceptor (2.7.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1247—DNA-directed RNA polymerase (2.7.7.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB0900974.7A 2009-01-21 2009-01-21 Mutant pathogenic bacteria and live attenuated vaccine compositions Ceased GB0900974D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0900974.7A GB0900974D0 (en) 2009-01-21 2009-01-21 Mutant pathogenic bacteria and live attenuated vaccine compositions
PCT/GB2010/050086 WO2010084350A1 (en) 2009-01-21 2010-01-21 Mutant pathogenic bacterial and live attenuated vaccine compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0900974.7A GB0900974D0 (en) 2009-01-21 2009-01-21 Mutant pathogenic bacteria and live attenuated vaccine compositions

Publications (1)

Publication Number Publication Date
GB0900974D0 true GB0900974D0 (en) 2009-03-04

Family

ID=40446122

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0900974.7A Ceased GB0900974D0 (en) 2009-01-21 2009-01-21 Mutant pathogenic bacteria and live attenuated vaccine compositions

Country Status (2)

Country Link
GB (1) GB0900974D0 (en)
WO (1) WO2010084350A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3092302A4 (en) 2014-01-06 2017-06-07 The United States of America, as Represented by the Secretary of Agriculture Attenuated salmonella enterica
CN113088454A (en) * 2021-04-08 2021-07-09 武汉轻工大学 Method for separating intact bacteria from infected cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE570745A (en) 1957-08-28
US4550081A (en) * 1980-05-19 1985-10-29 The Board Of Trustees Of The Leland Stanford Jr. University Non-reverting salmonella

Also Published As

Publication number Publication date
WO2010084350A1 (en) 2010-07-29

Similar Documents

Publication Publication Date Title
EP2476314A4 (en) Disinfectant composition and disinfecting method
IL219891A0 (en) Lipopeptide compositions and related methods
ZA201400725B (en) Methods and compositions for live attenuated viruses
AP3154A (en) Pesticide compositions including polymeric adjuvants
PT2547770T (en) Live attenuated chimeric porcine circovirus vaccine
IL217166A0 (en) Vaccines and compositions against stretococcus pneumoniae
GB0919333D0 (en) Sterilising emitter
EP2405770A4 (en) Compositions comprising monatin and calcium
IL214979A0 (en) Compositions and methods for elimination of gram-negative bacteria
IL209027A0 (en) Vaccine compositions and uses thereof
ZA201002515B (en) Live attenuated mycoplasma strains
IL215154A0 (en) Photodynamic disinfection compositions and uses thereof
GB2469565B (en) Attenuated Francisella bacterium
EP2334332A4 (en) Novel compositions and adjuvants
IL214127A0 (en) Vaccine compositions
EP2475393A4 (en) Formulation for room temperature stabilization of a live attenuated bacterial vaccine
GB201010717D0 (en) Disinfecting and sterilising solutions
IL220308A0 (en) Vaccine compositions
GB0900974D0 (en) Mutant pathogenic bacteria and live attenuated vaccine compositions
ZA201202924B (en) Compositions and methods for treating bacterial infections using ceftaroline
TWM370725U (en) Draft blower of bathroom
AU2009900736A0 (en) Live attenuated vaccines
ZA200808034B (en) Live attenuated salmonella vaccine
ZA200808033B (en) Live attenuated salmonella vaccine
GB0900943D0 (en) Vaccine compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)